Ex vivo T-cell depletion of bone marrow grafts with campath 1 prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation.

Samankaltaisia teoksia

• T-cell depletion of bone marrow grafts with Campath 1 ex vivo prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation
  Tekijä: Novitzky, N, et al.
  Julkaistu: (1997)
• Ex vivo depletion of T cells from bone marrow grafts with CAMPATH-1 in acute leukemia: graft-versus-host disease and graft-versus-leukemia effect.
  Tekijä: Novitzky, N, et al.
  Julkaistu: (1999)
• In vivo use of Campath-1G to prevent graft-versus-host disease and graft rejection after bone marrow transplantation.
  Tekijä: Willemze, R, et al.
  Julkaistu: (1992)
• Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.
  Tekijä: Heit, W, et al.
  Julkaistu: (1986)
• Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
  Tekijä: Hale, G, et al.
  Julkaistu: (1994)